Total Payments
$6,285
2024 Payments
$472.44
Companies
31
Transactions
313
Medicare Patients
16,628
Medicare Billing
$4.7M
Payment Breakdown by Category
Food & Beverage$6,060 (96.4%)
Education$225.84 (3.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,060 | 310 | 96.4% |
| Education | $225.84 | 3 | 3.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,224 | 55 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $799.74 | 39 | $0 (2023) |
| BIOTRONIK INC. | $713.14 | 10 | $0 (2021) |
| Merck Sharp & Dohme LLC | $532.54 | 24 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $488.31 | 23 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $350.57 | 16 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $344.53 | 16 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $324.20 | 16 | $0 (2023) |
| Akcea Therapeutics, Inc. | $219.17 | 5 | $0 (2019) |
| Gilead Sciences, Inc. | $215.66 | 48 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $472.44 | 26 | Amgen Inc. ($199.15) |
| 2023 | $592.29 | 25 | Merck Sharp & Dohme LLC ($310.72) |
| 2022 | $576.84 | 27 | Novartis Pharmaceuticals Corporation ($158.21) |
| 2021 | $1,096 | 39 | BIOTRONIK INC. ($290.96) |
| 2020 | $239.96 | 13 | Novartis Pharmaceuticals Corporation ($122.79) |
| 2019 | $1,300 | 54 | BIOTRONIK INC. ($232.88) |
| 2018 | $1,165 | 91 | Amgen Inc. ($396.92) |
| 2017 | $843.37 | 38 | Amgen Inc. ($335.09) |
All Payment Transactions
313 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $6.09 | General |
| Category: Cardiology | ||||||
| 10/31/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/24/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: Cardiology | ||||||
| 09/26/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: Cardiology | ||||||
| 09/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: Diabetes | ||||||
| 08/21/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: Cardiology | ||||||
| 08/07/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/07/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $6.31 | General |
| Category: Cardiology | ||||||
| 07/25/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: Not Applicable | ||||||
| 07/03/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/26/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: Cardiology | ||||||
| 06/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Diabetes | ||||||
| 05/29/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Cardiology | ||||||
| 05/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Diabetes | ||||||
| 05/08/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $6.11 | General |
| Category: Cardiology | ||||||
| 04/24/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: Cardiology | ||||||
| 04/23/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $28.24 | General |
| Category: Cardiovascular | ||||||
| 04/03/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Diabetes | ||||||
| 03/28/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Cardiology | ||||||
| 03/20/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/06/2024 | Medtronic, Inc. | CLOSUREFAST (Device) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: EndoVenous Therapies | ||||||
| 02/28/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $30.12 | General |
| Category: Cardiovascular | ||||||
| 02/22/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Cardiology | ||||||
| 02/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 3,314 | 7,900 | $1.8M | $903,589 |
| 2022 | 31 | 3,553 | 9,409 | $1.9M | $925,924 |
| 2021 | 36 | 4,967 | 13,980 | $2.9M | $1.5M |
| 2020 | 35 | 4,794 | 14,417 | $2.8M | $1.4M |
Total Patients
16,628
Total Services
45,706
Medicare Billing
$4.7M
Procedure Codes
132
All Medicare Procedures & Services
132 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 439 | 2,284 | $342,535 | $183,117 | 53.5% |
| G0166 | External counterpulsation, per treatment session | Office | 2023 | 47 | 1,276 | $350,900 | $145,768 | 41.5% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 108 | 109 | $141,700 | $101,249 | 71.5% |
| 93890 | Ultrasound of within the brain blood flow following medication | Office | 2023 | 207 | 209 | $94,050 | $62,691 | 66.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 299 | 1,658 | $140,945 | $48,707 | 34.6% |
| 93886 | Complete ultrasound of within the brain blood flow | Office | 2023 | 206 | 208 | $93,600 | $46,491 | 49.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 236 | 240 | $120,000 | $45,891 | 38.2% |
| 93892 | Ultrasound of within the brain blood flow for blood clots | Office | 2023 | 207 | 209 | $83,600 | $35,854 | 42.9% |
| 93975 | Complete ultrasound of abdomen and pelvis artery and vein blood flow | Office | 2023 | 133 | 133 | $59,850 | $35,808 | 59.8% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 149 | 158 | $51,350 | $31,524 | 61.4% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 104 | 108 | $43,200 | $26,298 | 60.9% |
| 36475 | Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | Office | 2023 | 19 | 23 | $66,700 | $25,929 | 38.9% |
| 95924 | Testing of autonomic (sympathetic and parasympathetic) nervous system function, at least 5 minutes of tilt | Office | 2023 | 148 | 148 | $37,000 | $21,744 | 58.8% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2023 | 135 | 137 | $37,675 | $17,838 | 47.3% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 74 | 76 | $22,800 | $14,151 | 62.1% |
| 93025 | Electrocardiogram (ecg) assessment of irregular heart beats | Office | 2023 | 90 | 90 | $27,000 | $10,788 | 40.0% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 136 | 137 | $20,550 | $9,803 | 47.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 78 | 80 | $16,000 | $6,400 | 40.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 47 | 47 | $11,750 | $6,395 | 54.4% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 85 | 87 | $17,400 | $5,557 | 31.9% |
| 93283 | Programming of dual lead implantable defibrillator system | Office | 2023 | 20 | 44 | $6,600 | $4,223 | 64.0% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2023 | 26 | 28 | $9,800 | $4,118 | 42.0% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 18 | 82 | $6,560 | $3,246 | 49.5% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 23 | 35 | $3,750 | $2,574 | 68.7% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 108 | 109 | $4,360 | $2,367 | 54.3% |
About Dr. Romesh Japra, M.D
Dr. Romesh Japra, M.D is a Cardiovascular Disease healthcare provider based in Fremont, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1144250184.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Romesh Japra, M.D has received a total of $6,285 in payments from pharmaceutical and medical device companies, with $472.44 received in 2024. These payments were reported across 313 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($6,060).
As a Medicare-enrolled provider, Japra has provided services to 16,628 Medicare beneficiaries, totaling 45,706 services with total Medicare billing of $4.7M. Data is available for 4 years (2020–2023), covering 132 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Internal Medicine
- Location Fremont, CA
- Active Since 07/04/2006
- Last Updated 02/09/2016
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1144250184
Products in Payments
- Repatha (Biological) $917.87
- ENTRESTO (Drug) $609.22
- ELIQUIS (Drug) $538.29
- VERQUVO (Drug) $532.54
- XARELTO (Drug) $324.20
- Corlanor (Drug) $305.65
- JARDIANCE (Drug) $242.02
- TEGSEDI (Drug) $219.17
- LEQVIO (Drug) $190.52
- PRALUENT ALIROCUMAB INJECTION (Biological) $128.40
- FARXIGA (Drug) $125.54
- BioMonitor (Device) $113.53
- Edora (Device) $98.00
- Verquvo (Drug) $97.22
- LOKELMA (Drug) $91.92
- Ozempic (Drug) $91.38
- PRADAXA (Drug) $90.94
- SYMBICORT (Drug) $81.77
- Solia (Device) $79.43
- LifeVest (Device) $72.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Fremont
Rajesh Suri, Md, MD
Cardiovascular Disease — Payments: $214,319
Cardiovascular Disease $214,319
Pradeep Kumar, Md Facc Fscai, MD FACC FSCAI
Cardiovascular Disease — Payments: $62,415
Cardiovascular Disease $62,415
Timothy Tsoi, M.d, M.D
Cardiovascular Disease — Payments: $32,104
Cardiovascular Disease $32,104
Carl Carlson, M.d, M.D
Cardiovascular Disease — Payments: $13,230
Cardiovascular Disease $13,230
Dr. Glynne Edwards, M.d, M.D
Cardiovascular Disease — Payments: $10,362
Cardiovascular Disease $10,362
Dr. Karim Hussain, Md, MD
Cardiovascular Disease — Payments: $6,670
Cardiovascular Disease $6,670